热门资讯> 正文
LifeStance股东发起3500万股二次发行
2026-05-08 04:58
- LifeStance Health (Nasdaq: LFST) said on Thursday that certain shareholders plan to sell 35 million shares of the company’s common stock in a secondary public offering.
- The company said it would not sell any shares in the offering and would not receive any proceeds.
- The selling shareholders will receive all proceeds from the sale.
- LifeStance also said it had authorized the concurrent repurchase of 6 million shares from the underwriter, subject to completion of the offering.
- The repurchase price will match the price paid by the underwriter to the selling shareholders.
- Source: Press Release
More on LifeStance Health Group
- Lifestance forecasts $1.64B-$1.68B 2026 revenue while targeting mid-teens adjusted EBITDA margins by 2028
- LifeStance Health Group GAAP EPS of $0.04 beats by $0.03, revenue of $403.5M beats by $17.38M
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。